Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Regarding the $55M inventory stocking number, what is your error bar around that number?

The error bar is pretty wide. On the 2Q15 CC, NVS said that inventory stocking was a “substantial” portion of Glatopa sales in the quarter, and my $55M and $70M estimates equate to inventory stocking comprising 79% of 2Q15 sales. If inventory stocking had comprised, say, 90% of 2Q15 sales, NVS might have used more forceful language to emphasize the degree of stocking.